dihydroergotamine has been researched along with methysergide in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (51.79) | 18.7374 |
| 1990's | 16 (28.57) | 18.2507 |
| 2000's | 7 (12.50) | 29.6817 |
| 2010's | 4 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamblin, MW; Monsma, FJ; Shen, Y; Sibley, DR; Ward, RP | 1 |
| Adham, N; Bard, JA; Branchek, TA; Vaysse, P; Weinshank, RL; Zgombick, J | 1 |
| Izzarelli, DG; Lewis-Higgins, L; Palmer, D; Parker, EM; Shapiro, RA | 1 |
| Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R | 1 |
| Boess, FG; Monsma, FJ; Sleight, AJ | 1 |
| Audia, JE; Krushinski, JH; Lucaites, VL; Nelson, DL; Schaus, JM; Wainscott, DB; Zgombick, JM | 1 |
| Fanchamps, A | 2 |
| Agarwal, KC; Steiner, M | 1 |
| Heyck, H | 1 |
| Fozard, JR | 1 |
| Berde, B | 1 |
| Diamond, S | 1 |
| Edvinsson, L; Hardebo, JE; Owman, C; Svendgaard, NA | 1 |
| Hackaday, J | 1 |
| Müller-Schweinitzer, E | 2 |
| Wilkinson, M | 1 |
| Aellig, WH | 1 |
| Oksenkryg, GF | 1 |
| Liaño, H | 1 |
| Ollat, H | 1 |
| Ashkenazi, A; Havlik, S; Jin, H; Marsters, SA; O'Dowd, BF; Oksenberg, D; Peroutka, SJ | 1 |
| Deliganis, AV; Peroutka, SJ | 1 |
| Bourin, M | 1 |
| Cavanna, M | 1 |
| Kunkel, RS | 1 |
| Bousser, MG; Massiou, H | 1 |
| Edmeads, JG | 1 |
| Pfaffenrath, V; Reiter, M | 1 |
| Durward, WF | 1 |
| Talalaenko, AN | 1 |
| Huffmann, G | 1 |
| Kanto, J | 1 |
| Meienberg, O; Orfei, R | 1 |
| Glusa, E; Markwardt, F | 1 |
| Neu, I; Pfaffenrath, V; Prosiegel, M | 1 |
| Saxena, PR; Spierings, EL | 1 |
| Maendly, R; Martinez Lage, JM; Mumenthaler, M | 1 |
| Sakanashi, M; Yonemura, KI | 1 |
| Liaño, H; López-Zuazo, I | 1 |
| Titus, F | 1 |
| Audinot-Bouchez, V; Chaput, C; Conte, C; Lavielle, G; Lochon, S; Millan, MJ; Newman-Tancredi, A; Verrièle, L | 1 |
| Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR | 1 |
| Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM | 1 |
| Autret, A; Mondon, K | 1 |
| Henry, P | 1 |
| Vaitkus, A; Vilionskis, A | 1 |
| Andrews, PL; Cheng, FH; Moreaux, B; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Wan, C | 1 |
| Centurión, D; Cobos-Puc, LE; González-Hernández, A; Lozano-Cuenca, J; Muñoz-Islas, E; Pertz, HH; Sánchez-López, A; Villalón, CM | 1 |
| Peatfield, R | 1 |
| Dahlöf, C; Maassen Van Den Brink, A | 1 |
| Rapoport, AM | 1 |
| Argüelles, CF; Godínez-Chaparro, B; Granados-Soto, V; López-Santillán, FJ; Villalón, CM | 1 |
15 review(s) available for dihydroergotamine and methysergide
| Article | Year |
|---|---|
The animal pharmacology of drugs used in the treatment of migraine.
Topics: Acetaminophen; Adrenergic alpha-Antagonists; Analgesics; Animals; Aspirin; Caffeine; Clonidine; Cyproheptadine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; Muscle, Smooth; Pizotyline; Serotonin Antagonists; Sympathetic Nervous System; Synaptic Transmission; Tryptamines; Vagus Nerve; Vasoconstrictor Agents; Vasodilator Agents | 1975 |
[Classification, pathogenesis and drug therapy of migraine and related forms of headache].
Topics: Adrenergic beta-Antagonists; Animals; Caffeine; Clonidine; Dihydroergotamine; Drug Synergism; Epinephrine; Ergotamine; Headache; Histamine; Humans; Methysergide; Mice; Migraine Disorders; Norepinephrine; Pizotyline; Serotonin | 1975 |
Pharmacology of ergot alkaloids in clinical use.
Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction | 1978 |
[Current treatment of migraine].
Topics: Adult; Child; Dihydroergotamine; Ergotamine; Female; Humans; Indoles; Male; Methysergide; Metoclopramide; Middle Aged; Migraine Disorders; Sulfonamides; Sumatriptan; Time Factors; Vasoconstrictor Agents | 1992 |
[Serotonin agonists and antagonists in migraine].
Topics: Benzoxepins; Contraindications; Cyproheptadine; Dihydroergotamine; Ergotamine; Histamine H1 Antagonists; Humans; Indoles; Methysergide; Migraine Disorders; Phenothiazines; Pizotyline; Receptors, Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1992 |
[Therapy of headache].
Topics: Cluster Headache; Dextropropoxyphene; Dihydroergotamine; Domperidone; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Pizotyline; Prednisolone; Prednisone; Vascular Headaches | 1989 |
Pharmacologic management of migraine--1985.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Calcium Channel Blockers; Dihydroergotamine; Humans; Lithium; Lithium Carbonate; Methysergide; Metoclopramide; Migraine Disorders; Receptors, Adrenergic, alpha; Vasodilator Agents | 1985 |
Migraine.
Topics: Acute Disease; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Analgesics; Calcium Channel Blockers; Chlorpromazine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Narcotics; Pizotyline | 1988 |
[Drug therapy of migraine].
Topics: Adrenergic beta-Antagonists; Analgesics; Antiemetics; Cerebrovascular Circulation; Dihydroergotamine; Humans; Locus Coeruleus; Methysergide; Migraine Disorders; Raphe Nuclei | 1988 |
Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
Topics: Absorption; Animals; Bromocriptine; Dihydroergotamine; Ergolines; Ergot Alkaloids; Ergotamine; Half-Life; Humans; Kinetics; Methysergide | 1983 |
[Treatment of cluster headache (author's transl)].
Topics: Adult; Cluster Headache; Cortisone; Dihydroergotamine; Humans; Indomethacin; Lithium; Lithium Carbonate; Methysergide; Vascular Headaches | 1982 |
[Prophylactic treatment of episodic forms of cluster headache].
Topics: Adrenal Cortex Hormones; Alkaloids; Calcium Channel Blockers; Capsaicin; Cluster Headache; Dihydroergotamine; Ergotamine; Humans; Lithium; Methysergide; Serotonin Antagonists; Tranquilizing Agents; Vasoconstrictor Agents | 1995 |
[The problems of migraine headache treatment].
Topics: Aged; Analgesics; Analgesics, Non-Narcotic; Aspirin; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Stress, Psychological; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents | 2002 |
Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
Topics: Animals; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Sumatriptan; Treatment Outcome | 2012 |
What happens to the old headache medicines?
Topics: Analgesics; Clinical Trials as Topic; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Tryptamines | 2012 |
41 other study(ies) available for dihydroergotamine and methysergide
| Article | Year |
|---|---|
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain Chemistry; Cell Line; Cloning, Molecular; DNA; GTP-Binding Proteins; Lysergic Acid Diethylamide; Molecular Sequence Data; Polymerase Chain Reaction; Psychotropic Drugs; Rats; Receptors, Serotonin; RNA; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1993 |
Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
Topics: Adenylyl Cyclases; Base Sequence; Cloning, Molecular; DNA Primers; Humans; Molecular Sequence Data; Receptors, Serotonin; Sequence Alignment; Sequence Homology, Amino Acid; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction | 1993 |
Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Binding, Competitive; Chlorocebus aethiops; Cloning, Molecular; COS Cells; DNA Primers; Ergolines; Glutamic Acid; Humans; Isoleucine; Kinetics; Ligands; Lysine; Models, Structural; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Protein Structure, Secondary; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Serine; Serotonin; Transfection | 1996 |
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents | 1996 |
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
Topics: Adenylyl Cyclases; Amino Acid Substitution; Binding Sites; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Ligands; Lysergic Acid Diethylamide; Mutagenesis, Site-Directed; Mutation; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1998 |
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.
Topics: Animals; Benzamides; Brain; Cells, Cultured; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Ligands; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Serotonin Receptor Agonists; Transfection; Tritium | 2005 |
[Mechanism of action of drugs currently used in the prevention of migraine].
Topics: Adrenergic beta-Antagonists; Catecholamines; Cerebrovascular Circulation; Chemical Phenomena; Chemistry; Clonidine; Dihydroergotamine; Ergotamine; Histamine Release; Humans; Kinins; Methysergide; Migraine Disorders; Pizotyline; Serotonin Antagonists | 1976 |
Effect of serotonin on cyclic nucleotides of human platelets.
Topics: Biological Transport; Blood Platelets; Cyclic AMP; Cyclic GMP; Dihydroergotamine; Dose-Response Relationship, Drug; Formaldehyde; Glutaral; Humans; Imipramine; Kinetics; Methysergide; Serotonin | 1976 |
[Drug therapy of migraine and cluster headache].
Topics: Analgesics; Barbiturates; Caffeine; Dihydroergotamine; Drug Synergism; Ergot Alkaloids; Headache; Histamine H1 Antagonists; Humans; Methysergide; Migraine Disorders; Vascular Headaches | 1975 |
Cluster headache: relation to and comparison with migraine.
Topics: Cluster Headache; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Prednisone; Vascular Headaches | 1979 |
Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
Topics: Animals; Arteries; Cats; Cerebral Arteries; Cyproheptadine; Dihydroergotamine; Drug Synergism; Ergotamine; Humans; In Vitro Techniques; Methysergide; Migraine Disorders; Pizotyline; Serotonin; Serotonin Antagonists; Vasoconstriction; Vasomotor System | 1978 |
Migraine. Prophylactic drugs.
Topics: Anticonvulsants; Clonidine; Cyproheptadine; Dihydroergotamine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol; Tranquilizing Agents | 1977 |
Studies on the 5-HT receptor in vascular smooth muscle.
Topics: Animals; Basilar Artery; Cattle; Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; In Vitro Techniques; Methysergide; Muscle, Smooth; Pizotyline; Receptors, Serotonin; Thiophenes | 1978 |
[The use of drugs in migraine].
Topics: Acetaminophen; Antiemetics; Aspirin; Clonidine; Dihydroergotamine; Ergotamine; Humans; Hypnotics and Sedatives; Methysergide; Migraine Disorders; Tranquilizing Agents | 1976 |
[Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
Topics: Blood Pressure; Dihydroergotamine; Dose-Response Relationship, Drug; Ergot Alkaloids; Ergotamine; Hand; Humans; Methysergide; Vascular Resistance; Veins | 1976 |
[Effect of D-, M- and T-antagonists of serotonin on its absorption by human thrombocytes].
Topics: Absorption; Blood Platelets; Cocaine; Depression, Chemical; Dihydroergotamine; Humans; Indoles; Methysergide; Morphine; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1976 |
A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.
Topics: Alprenolol; Amino Acid Sequence; Animals; Base Sequence; Dihydroergotamine; Humans; In Vitro Techniques; Methiothepin; Methysergide; Mice; Molecular Sequence Data; Pindolol; Propranolol; Rats; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1992 |
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Cattle; Caudate Nucleus; Dihydroergotamine; Ergotamine; Indoles; Kinetics; Methysergide; Migraine Disorders; Radioligand Assay; Receptors, Serotonin; Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Verapamil | 1991 |
[Serotonin and antiserotonergic agents].
Topics: Cyproheptadine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Pizotyline; Serotonin; Serotonin Antagonists | 1990 |
[Antimigrainous agents used in maintenance treatment].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnarizine; Clonidine; Dihydroergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol | 1986 |
The management of migraine.
Topics: Clonidine; Diet; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Pizotyline; Propranolol | 1985 |
[Participation of monoaminergic mechanisms of the rat hypothalamus in conditioned avoidance reactions].
Topics: Aminobutyrates; Animals; Avoidance Learning; Depression, Chemical; Dihydroergotamine; GABA Antagonists; gamma-Aminobutyric Acid; Hypothalamus; Male; Methysergide; Morphine; Motor Activity; Muscle Tonus; Norepinephrine; Phentolamine; Propranolol; Rats; Reaction Time; Serotonin; Serotonin Antagonists; Stimulation, Chemical | 1973 |
[What is safe in the treatment of headache?].
Topics: Anti-Anxiety Agents; Benzodiazepines; Cerebrovascular Disorders; Cluster Headache; Delayed-Action Preparations; Dihydroergotamine; Dihydroergotoxine; Headache; Humans; Methysergide; Migraine Disorders; Vascular Headaches | 1981 |
Carotidynia: report of eight cases and prospective evaluation of therapy.
Topics: Adult; Aged; Carotid Artery Diseases; Dihydroergotamine; Female; Flurbiprofen; Humans; Indomethacin; Male; Methysergide; Middle Aged; Pain; Syndrome | 1983 |
Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
Topics: Dihydroergotamine; Femoral Artery; Femoral Vein; Humans; In Vitro Techniques; Methysergide; Pizotyline; Receptors, Serotonin; Serotonin; Vasoconstriction | 1984 |
Vascular effects of ergot alkaloids: a study on human basilar arteries.
Topics: Basilar Artery; Cocaine; Dihydroergotamine; Ergot Alkaloids; Ergotamine; Humans; In Vitro Techniques; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Serotonin | 1983 |
Pharmacology of arteriovenous anastomoses.
Topics: Animals; Arteriovenous Anastomosis; Cats; Cerebrovascular Circulation; Dihydroergotamine; Ergotamine; Humans; Methylamines; Methysergide; Migraine Disorders; Sympathomimetics | 1982 |
[Erythroprosopalgia. Review including 224 own observations].
Topics: Adult; Age Factors; Cluster Headache; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Humans; Indomethacin; Lithium; Male; Methysergide; Middle Aged; Prednisone; Sex Factors; Trigeminal Neuralgia; Vascular Headaches | 1982 |
On the mode of action of ergometrine in the isolated dog coronary artery.
Topics: Animals; Arteries; Coronary Vessels; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Ergonovine; In Vitro Techniques; Methysergide; Phenoxybenzamine; Phentolamine; Receptors, Serotonin; Serotonin; Vasoconstriction | 1980 |
[The treatment of migraine].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Nicardipine; Nimodipine; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1997 |
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Cell Membrane; Cricetinae; Dihydroergotamine; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Lisuride; Methysergide; Migraine Disorders; Piperazines; Piperidines; Pizotyline; Propranolol; Propylamines; Protein Binding; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 1997 |
Coronary side-effect potential of current and prospective antimigraine drugs.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 1998 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 1999 |
[Migraine and facial pain].
Topics: Adult; Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Child; Diagnosis, Differential; Dihydroergotamine; Facial Pain; Female; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Oxygen Inhalation Therapy; Psychotherapy; Serotonin Antagonists; Sumatriptan; Time Factors; Trigeminal Neuralgia; Vasoconstrictor Agents | 2001 |
[Migraine: a disease, not a symptom].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Diagnosis, Differential; Dihydroergotamine; Flunarizine; GABA Agents; Humans; Indoramin; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Valproic Acid; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
Fibrosis due to ergot derivatives: exposure to risk should be weighed up.
Topics: Dihydroergotamine; Ergotamine; Fibrosis; France; Humans; Methysergide; Risk Assessment; Risk Factors | 2002 |
Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Butanols; Capsaicin; Cyclooxygenase Inhibitors; Dihydroergotamine; Diphenhydramine; Diterpenes; Domperidone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Indomethacin; Malates; Methysergide; Metoclopramide; Migraine Disorders; Ondansetron; Piperidines; Ruthenium Red; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists; Shrews; Sumatriptan; Time Factors; Tropanes; Vomiting | 2005 |
Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Pressure; Decerebrate State; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Combinations; Electric Stimulation; Heart Rate; Hemodynamics; Male; Methysergide; Norepinephrine; Oxadiazoles; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic, alpha-2; Serotonin Antagonists; Sympathetic Nervous System; Tachycardia; Yohimbine | 2009 |
Headache currents commentary.
Topics: Analgesics; Animals; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Sumatriptan | 2012 |
Role of 5-HT₁B/₁D receptors in the reduction of formalin-induced nociception and secondary allodynia/hyperalgesia produced by antimigraine drugs in rats.
Topics: Acute Pain; Animals; Biphenyl Compounds; Chronic Pain; Dihydroergotamine; Disease Models, Animal; Drug Therapy, Combination; Female; Formaldehyde; Hyperalgesia; Methysergide; Nociceptive Pain; Piperazines; Piperidones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Antagonists; Spiro Compounds; Sumatriptan | 2013 |